Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors за авторством Katrina M. Lappin (9340394)

Інші автори:

Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors за авторством Katrina M. Lappin (9340394)

Інші автори:

Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors за авторством Katrina M. Lappin (9340394)

Інші автори:

Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors за авторством Katrina M. Lappin (9340394)

Інші автори:

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification за авторством Robert L. Hollis (15034814)

Інші автори:

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification за авторством Robert L. Hollis (15034814)

Інші автори:

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification за авторством Robert L. Hollis (15034814)

Інші автори:

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification за авторством Robert L. Hollis (15034814)

Інші автори:

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification за авторством Robert L. Hollis (15034814)

Інші автори:

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification за авторством Robert L. Hollis (15034814)

Інші автори: